This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ohtsuka, T. Articles by Hiwada, K. Search for Related Content PubMed PubMed Citation Articles by Ohtsuka, T. Articles by Hiwada, K.

Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy

^a Second Department of Internal Medicine, Ehime University School of Medicine, Ehime, Japan

View larger version (28K): [in a new window]   Figure 1 Graphs showing the serum levels of IL-10 (A), TNF-alpha (B), sTNF-R1 (C) and sTNF-R2 (D) in 10 age-matched control subjects and in 32 patients with DCM at baseline. *p < 0.05. **p < 0.005 vs. control subjects.

View larger version (22K): [in a new window]   Figure 2 Scatterplots showing a correlation between IL-10 and TNF-alpha in 32 patients with DCM.

View larger version (20K): [in a new window]   Figure 3 Scatterplots showing correlations (A) between sTNF-R2 and left ventricular end-diastolic dimension (LVEDD) and (B) between plasma epinephrine levels and the TNF-alpha/IL-10 ratio in 32 patients with DCM.

View larger version (44K): [in a new window]   Figure 4 Comparisons of serum levels of IL-10 (A), TNF-alpha (B), sTNF-R1 (C) and sTNF-R2 (D) at baseline and 12 weeks after the initiation of beta-blocker therapy in 32 patients with DCM. *p < 0.005. **p < 0.001 vs. control subjects.